OHR Pharmaceutical Inc Share Price Nasdaq
Equities
US67778H2004
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 1.28M 101M |
---|---|---|---|---|---|
Net income 2023 * | -12M -950M | Net income 2024 * | - | EV / Sales 2023 * | - |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 86.62% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Branning
CEO | Chief Executive Officer | 54 | 09/01/22 |
Dani Stoltzfus
PRN | Corporate Officer/Principal | - | - |
Ron Sarkar
PRN | Corporate Officer/Principal | - | 31/10/21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dov Goldstein
CHM | Chairman | 56 | 11/07/19 |
Eric Richman
BRD | Director/Board Member | 63 | 11/07/19 |
Gerald McDougall
BRD | Director/Board Member | 57 | 10/05/21 |
1st Jan change | Capi. | |
---|---|---|
+35.75% | 51.51B | |
-6.24% | 39.03B | |
+35.11% | 38.91B | |
-12.11% | 26.68B | |
+12.23% | 26.13B | |
-16.06% | 19.91B | |
+42.62% | 13.71B | |
+30.54% | 12.38B | |
-3.42% | 11.74B |